Viela is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. We believe that our approach â which targets the underlying molecular pathogenesis of the disease â enables us to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of our product candidates.
Source
